Aion Therapeutic Inc

Healthcare US ANTCF

0.002USD
0.00(0%)

Last update at 2026-06-02T20:00:00Z

Day Range

0.0020.002

LowHigh

52 Week Range

0.00130.02

LowHigh

Fundamentals

Previous Close 0.002
Market Cap9.42M
Volume15000
P/E Ratio-
Dividend Yield-%
EBITDA-1.49395M
Revenue TTM1.47M
Revenue Per Share TTM0.003
Gross Profit TTM 0.48M
Diluted EPS TTM-0.01

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2024-04-30	2023-04-30	2022-04-30	2021-04-30	2020-04-30
Type	yearly	yearly	yearly	yearly	yearly
Date	2024-04-30	2023-04-30	2022-04-30	2021-04-30	2020-04-30
Income before tax	-6.28720M	-0.25666M	-3.81839M	-8.26515M	-0.67283M
Minority interest	-	-	-	-	-
Net income	-6.28720M	-0.25666M	-3.81839M	-8.26515M	-0.67283M
Selling general administrative	0.97M	0.59M	1.80M	2.65M	0.85M
Selling and marketing expenses	0.05M	-	-	-	0.00202M
Gross profit	0.16M	-	-	-	-
Reconciled depreciation	0.04M	0.02M	0.07M	0.13M	0.11M
Ebit	-6.11580M	-0.85964M	-2.81891M	-2.78002M	-0.99664M
Ebitda	-6.07370M	-0.08951M	-2.75362M	-2.65189M	-0.88559M
Depreciation and amortization	0.04M	-	0.07M	0.13M	0.11M
Non operating income net other	-	-	-	-	-
Operating income	-1.19095M	-0.97570M	-2.81891M	-2.78002M	-0.99664M
Other operating expenses	0.37M	-	2.82M	2.78M	0.98M
Interest expense	0.17M	0.15M	0.08M	0.19M	0.32M
Tax provision	-	-	-	-	-
Interest income	0.01M	-	-	-	-
Net interest income	-0.15640M	-0.14984M	-0.07572M	-0.18607M	-0.33519M
Extraordinary items	-	-	-	-	-
Non recurring	-	-	-	-	-
Other items	-	-	-	-	-
Income tax expense	-	-	0.08M	0.19M	0.32M
Total revenue	0.37M	0.00000M	0.00000M	0.00000M	0.00000M
Total operating expenses	0.16M	0.98M	2.82M	2.78M	0.98M
Cost of revenue	0.20M	-	-	-	-
Total other income expense net	-6.28720M	0.87M	-0.92376M	-5.29906M	0.65M
Discontinued operations	-	-	-	-	-
Net income from continuing ops	-6.28720M	-0.25666M	-3.81839M	-8.26515M	-0.67283M
Net income applicable to common shares	-	-0.25666M	-3.81839M	-8.26515M	-0.67283M
Preferred stock and other adjustments	-	-	-	-	-

Breakdown	2024-04-30	2023-04-30	2022-04-30	2021-04-30	2020-04-30
Type	yearly	yearly	yearly	yearly	yearly
Date	2024-04-30	2023-04-30	2022-04-30	2021-04-30	2020-04-30
Total assets	0.70M	0.21M	0.15M	1.60M	3.34M
Intangible assets	-	-	-	-	-
Earning assets	-	-	-	-	-
Other current assets	0.01M	-	-	0.02M	0.02M
Total liab	4.57M	2.94M	2.56M	1.21M	1.20M
Total stockholder equity	-3.87185M	-2.72583M	-2.40661M	0.40M	2.13M
Deferred long term liab	-	-	-	-	-
Other current liab	-	0.28M	0.37M	0.01M	0.15M
Common stock	19.43M	14.79M	14.71M	13.26M	7.73M
Capital stock	-	14.79M	14.71M	13.26M	7.73M
Retained earnings	-26.36440M	-20.07720M	-19.82054M	-16.00215M	-7.73700M
Other liab	-	-	-	-	-
Good will	-	-	-	-	-
Other assets	-	-	-	0.56M	0.06M
Cash	0.07M	0.00034M	0.00000M	0.24M	0.61M
Cash and equivalents	-	-	-	-	-
Total current liabilities	4.57M	2.94M	2.56M	1.21M	0.48M
Current deferred revenue	-	-	-	-	-
Net debt	2.01M	0.83M	0.74M	0.33M	0.35M
Short term debt	2.08M	-	0.74M	0.57M	0.24M
Short long term debt	-	0.83M	0.74M	0.50M	0.12M
Short long term debt total	2.08M	-	0.74M	0.57M	0.96M
Other stockholder equity	3.19M	2.17M	2.64M	3.00M	2.15M
Property plant equipment	-	-	-	0.56M	2.53M
Total current assets	0.53M	0.20M	0.15M	0.47M	0.75M
Long term investments	-	0.01M	-	-	-
Net tangible assets	-	-2.72583M	-2.40661M	0.40M	2.13M
Short term investments	-	-	-	-	-
Net receivables	0.05M	0.20M	0.14M	-	0.07M
Long term debt	-	-	-	-	0.43M
Inventory	0.40M	-	-	-	-
Accounts payable	2.49M	1.68M	1.81M	0.63M	0.09M
Total permanent equity	-	-	-	-	-
Noncontrolling interest in consolidated entity	-	-	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-	-	-
Accumulated other comprehensive income	-0.12979M	-	0.07M	0.14M	-
Additional paid in capital	-	-	-	-	-
Common stock total equity	-	-	-	-	-
Preferred stock total equity	-	-	-	-	-
Retained earnings total equity	-	-	-	-	-
Treasury stock	-	-	-	-	-
Accumulated amortization	-	-	-	-	-
Non currrent assets other	-	-	-	0.56M	0.06M
Deferred long term asset charges	-	-	-	-	-
Non current assets total	0.17M	0.01M	0.00000M	1.13M	2.59M
Capital lease obligations	-	-	0.00000M	0.07M	0.41M
Long term debt total	-	-	-	-	-

Breakdown	2024-04-30	2023-04-30	2022-04-30	2021-04-30	2020-04-30
Type	yearly	yearly	yearly	yearly	yearly
Date	2024-04-30	2023-04-30	2022-04-30	2021-04-30	2020-04-30
Investments	-0.28942M	0.14M	0.00000M	-1.38003M	-0.33319M
Change to liabilities	-	0.80M	1.19M	0.42M	0.00490M
Total cashflows from investing activities	-0.28942M	0.14M	0.14M	-1.38003M	-0.20463M
Net borrowings	0.00204M	0.06M	0.11M	-0.27368M	-0.25356M
Total cash from financing activities	1.12M	0.16M	1.20M	3.00M	-0.12500M
Change to operating activities	-	-0.04724M	0.15M	-0.19661M	0.27M
Net income	-6.28720M	-0.25666M	-3.81839M	-8.26515M	-0.67283M
Change in cash	0.07M	0.00034M	-0.23983M	-0.37296M	-1.00994M
Begin period cash flow	0.00034M	0.00000M	0.24M	0.61M	1.62M
End period cash flow	0.07M	0.00034M	0.00000M	0.24M	0.61M
Total cash from operating activities	-0.84505M	-0.04140M	-1.34689M	-2.13348M	-0.55175M
Issuance of capital stock	0.54M	0.00000M	1.11M	2.95M	-
Depreciation	0.04M	0.02M	0.07M	0.13M	0.11M
Other cashflows from investing activities	-0.28942M	-	-	0.06M	0.06M
Dividends paid	-	-	-	-	-
Change to inventory	-0.07689M	-	-	-	-
Change to account receivables	0.17M	-	-	-	-
Sale purchase of stock	-	-	-	-	-
Other cashflows from financing activities	0.58M	-	0.65M	0.33M	-0.33319M
Change to netincome	-	-0.55457M	1.07M	5.71M	-0.34454M
Capital expenditures	0.00000M	0.00000M	0.00000M	1.44M	0.20M
Change receivables	-	-	-	-	-
Cash flows other operating	-	-	-	-	-
Exchange rate changes	-	-	-	-	-
Cash and cash equivalents changes	-	-	-	-	-
Change in working capital	0.35M	0.75M	1.34M	0.23M	0.27M
Stock based compensation	-	-	0.00000M	0.45M	0.00000M
Other non cash items	5.05M	0.15M	1.07M	5.32M	-0.26241M
Free cash flow	-0.84505M	-0.04140M	-1.34689M	-3.57832M	-0.75638M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company	Change (USD)	Price (USD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)	Enterprise Value to EBITDA (x)
ANTCF Aion Therapeutic Inc	- -%	0.002	-	-	6.40	4.13	2.83	-1.103
ZTS Zoetis Inc	1.20 1.57%	77.59	40.18	30.96	10.67	17.60	11.27	26.18
MKKGY Merck KGaA ADR	0.58 1.91%	31.01	21.25	14.93	3.10	2.14	3.60	12.98
MKGAF MERCK Kommanditgesellschaft auf Aktien	- -%	153.91	21.73	14.95	3.16	2.15	3.56	12.82
GALDY GALDERMA GROUP AG	-0.79 1.89%	40.92	74.21	41.67	8.64	5.55	9.15	42.22

Reports Covered

View All

Profile

Aion Therapeutic Inc. engages in the health and wellness business in the United States. The company was formerly known as Osoyoos Cannabis Inc. and changed its name to Aion Therapeutic Inc. in August 2020. Aion Therapeutic Inc. was incorporated in 2011 and is based in Vancouver, Canada.

Aion Therapeutic Inc

700 West Georgia Street, Vancouver, BC, Canada, V7Y 1K8

416 460 3000
https://www.aiontherapeutic.com/

Key Executives

Name	Title	Year Born
Mr. Graham Simmonds	CEO, COO & Exec. Vice Chair of Board	NA
Mr. Rakesh Malhotra B.Com., C.A., F.C.A., FCA (India), C.P.A., CPA, (U	Chief Financial Officer	1955
Dr. Anthony J. Hall F.A.C.S., FAANS, M.D.	Medical Director & Independent Director	NA
Ms. Patricia Purdy	Corp. Sec.	1947
Mr. Paul Burke	Pres of AI Pharmaceuticals	NA
Mr. John Graham Simmonds Jr.	CEO, COO & Executive Vice Chair of Board	1974
Mr. Rakesh Malhotra (US), B.Com., C.A., C.P.A., CA (Canada), F.C.A., F	Chief Financial Officer	1955
Ms. Patricia Purdy	Corporate Secretary	1947

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.